Orbimed Advisors LLC, Director at Sionna Therapeutics, Inc. (SION), sold 510,583 shares at $44.51 ($22.9M) on 2026-04-14, disclosed to the SEC on 2026-04-16.
Scheduled sale ($22.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.51 | 47,814 | $2.1M | 9.3% |
| 2 | $44.64 | 235,863 | $10.5M | 45.9% |
| 3 | $45.34 | 226,906 | $10.3M | 44.8% |
| Total | $44.94 avg | 510,583 | $22.9M | 100% |
| Filing → |
| BRVE | BUY | 2026-08-11 | $34.9M | — | Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| SION | SELL | 2026-07-09 | $3.9M | — | Filing → |